Publications

therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated plasmodium falciparum malaria in kampong speu, cambodia.

cambodia stopped using co-blistered, non-fixed, artesunate-mefloquine (asmq) in 2008 when treatment failure rates approximated 20%. fixed dose combination (fdc) asmq is efficacious against acute uncomplicated, drug resistant plasmodium falciparum malaria in southeast asia but has not been tested in cambodia.